ODM-201 Inhibitor for Prostate Cancer
Neal D. Shore, MD, FACS discusses the androgen receptor inhibitor ODM-201 for castration-resistant prostate cancer.

New Biomarkers in Prostate Cancer
By E. David Crawford, MD, Karen Ventii, PhD, and Neal D. Shore, MD

Current Treatment Options for Metastatic, Castrate-Resistant Prostate Cancer

Welcome to Carolina Urologic Research Center
Carolina Urologic Research Center (CURC), is a separate and independent research arm of Grand Strand Urology, a division of Atlantic Urology Clinics in Myrtle Beach, South Carolina. Under the direction of Dr. Neal Shore, CURC conducts phase I - IV drug, biotechnology and device trials focusing on urological diseases. CURC has been recognized both nationally & internationally as one of the most progressive, well-organized, and respected clinical research sites in the United States.

March 2014
See Dr. Shore and his fellow expert panel discuss Genomic Testing for Newly Diagnosed Low-Risk Prostate Cancer in this recently released Roundtable Video.
April 2014
Is Radiotherapy with XOFIGO Safe? Dr. Neal Shore explains the safety of this approach.